UnitedHealth Group Inc (UNH) Buy, Sell or Hold

UnitedHealth Group Inc (UNH)

400.26

-0.70 (0.17%)

as of Jun 18, 2026, 11:51:10 pm Market Open.

115 watching

BUY

Got hurt by Humana's bad report number, but UNH didn't suffer Medicare-related problems like Humana. Rather, UNH reported insanely strong numbers. It's a buying opportunity now. Sees strong upside.

Wealthica Track your Stocks in your Watch List

PAST TOP PICK

(A Top Pick Sep 28/20, Up 63%) It continues to do well. It's an insurer, but passed on the actual costs to their health suppliers, as they collect the premiums and maintain fixed costs. This business model has been working well. Is it ethical? One could argue it is, but it's worked for UHN.

DON'T BUY

In the space, he owns ANTM instead, which is half the size. Both have HMOs and PBMs. ANTM is cheaper, and it has as good, if not better, future prospects. 5-year chart shows them running neck-and-neck. Medicare for all is a long way out, given the huge US debt.

BUY

Don't fear a shutdown, but a slowdown due to the new Omicron variant. Best among the health insurers. He also likes Centene. If you can, buy a fractional share, if the price is too high.

DON'T BUY

UNH vs. ANTM He owns ANTM instead, with a valuation of 6-8 multiple points less expensive than UNH. ANTM is well managed, growth rates are very good, and medical cost ratios are inline.

BUY

Allan Tong’s Discover Picks UNH it trades at 28.1x PE, which is slightly higher than its peers's average of 26.5x. Return on assets is higher, though, at 7.43% vs. 6.47% as is ROE at 21.88% vs. 18.86%. UNH stock's 1.36% may seem small, but it is in line with its peers and safe at a 34% payout ratio. The street loves this name at 14 buys and two holds, but sees only 7.5% upside from here. This isn't a trade a stock, but a long-term hold that you build on dips over time. It's enjoyed a 35% move in the past 12 months and has sharply climbed since Feb. 15. It's time for this to take a breather, which is the investor's cue to enter with a stock buying opportunity. Read Buying the Dip – A Stock Buying Opportunity for our full analysis.

BUY ON WEAKNESS

Great name to own, stable, consistent grower. You can try to build a position on a pullback. Nice long-term hold.

BUY

They report Thursday. Healthcare so far is avoiding Biden's anti-trust efforts. The stock is over $400, but it's still viable. He foolishly sold his shares earlier.

Wealthica Track your Stocks in your Watch List

TOP PICK

No other US company comes close to their scale and size. Mix of services produces steady and reliable sales. Great technical chart for 10 years. Beat expectation last quarter. Expects earnings growth to top 14% over the next few years. Dividend will continue to grow. Yield is 1.45%. (Analysts’ price target is $441.36)

PAST TOP PICK

(A Top Pick Jan 17/20, Up 14%) An easy hold. Great visibility. Managed care. Commercial health insurance, plus one of the key administrators of Medicare and Medicaid. Enjoys bipartisan support. Underlying businesses are doing great.

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK

(A Top Pick Aug 25/20, Up 5.69%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with UNH has triggered our $330 stop level. Given the technical breakdown that points to further potential downward moves, we are recommending covering the entire position at this time. We will consider it for future acquisition at lower levels.

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK

(A Top Pick Aug 25/20, Up 15.3%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with UNH is moving well. We are recommending to trail up the stop to $330, which should all but guarantee a minimum return of 10%.

PAST TOP PICK

(A Top Pick Sep 28/20, Up 15%) Trying to be more proactive in getting patients treated and cutting costs. Encourages healthcare providers to be efficient. An ounce of prevention is worth a pound of cure.

HOLD

You have to endure a few really bad quarters before this bounces back. Don't chase it.

BUY

This stock should skate through a change in administration or even another Trump term. Americans are quite happy with private healthcare solutions. 180M Americans have some sort of private health. 75% are happy with this so it would probably not be disrupted in a large way. He prefers Anthem but there is no problem with UNH.

Showing 61 to 75 of 190 entries

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

UnitedHealth Group Inc (UNH)